{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:50:35Z","timestamp":1775739035259,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00592-019-01310-z","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:02:57Z","timestamp":1553256177000},"page":"777-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study"],"prefix":"10.1007","volume":"56","author":[{"name":"For the International Retina Group","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-4663","authenticated-orcid":false,"given":"Catharina","family":"Busch","sequence":"first","affiliation":[]},{"given":"Samantha","family":"Fraser-Bell","sequence":"additional","affiliation":[]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[]},{"given":"Patricio J.","family":"Rodr\u00edguez-Vald\u00e9s","sequence":"additional","affiliation":[]},{"given":"Zafer","family":"Cebeci","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Lupidi","sequence":"additional","affiliation":[]},{"given":"Adrian T.","family":"Fung","sequence":"additional","affiliation":[]},{"given":"Pierre-Henry","family":"Gabrielle","sequence":"additional","affiliation":[]},{"given":"Ermete","family":"Giancipoli","sequence":"additional","affiliation":[]},{"given":"Voraporn","family":"Chaikitmongkol","sequence":"additional","affiliation":[]},{"given":"Mali","family":"Okada","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"La\u00edns","sequence":"additional","affiliation":[]},{"given":"Ana Rita","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Paradee","family":"Kunavisarut","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Sala-Puigdollers","sequence":"additional","affiliation":[]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[]},{"given":"Malgorzata","family":"Ozimek","sequence":"additional","affiliation":[]},{"given":"Assaf","family":"Hilely","sequence":"additional","affiliation":[]},{"given":"Jan Darius","family":"Unterlauft","sequence":"additional","affiliation":[]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[]},{"given":"Matias","family":"Iglicki","sequence":"additional","affiliation":[]},{"given":"Matus","family":"Rehak","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"issue":"6","key":"1310_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00592-017-0984-z","volume":"54","author":"AI Arroba","year":"2017","unstructured":"Arroba AI, Valverde AM (2017) Modulation of microglia in the retina: new insights into diabetic retinopathy. Acta Diabetol 54(6):527\u2013533","journal-title":"Acta Diabetol"},{"issue":"3","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564","journal-title":"Diabetes Care"},{"issue":"4","key":"1310_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM et al Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012;119(4):789\u2013801","journal-title":"Ophthalmology"},{"issue":"13","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research N, Wells JA, Glassman AR et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 2015;372(13):1193\u20131203","journal-title":"N Engl J Med"},{"issue":"12","key":"1310_CR5","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","volume":"121","author":"MC Gillies","year":"2014","unstructured":"Gillies MC, Lim LL, Campain A et al (2014) A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 121(12):2473\u20132481","journal-title":"Ophthalmology"},{"issue":"10","key":"1310_CR6","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10):1904\u20131914","journal-title":"Ophthalmology"},{"issue":"10","key":"1310_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/bjo.2008.146712","volume":"93","author":"J Figueira","year":"2009","unstructured":"Figueira J, Khan J, Nunes S et al (2009) Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 93(10):1341\u20131344","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/IAE.0b013e31818144a7","volume":"28","author":"MS Ip","year":"2008","unstructured":"Ip MS, Bressler SB, Antoszyk AN et al (2008) A randomized trial comparing intravitreal triamcinolone and focal\/grid photocoagulation for diabetic macular edema: baseline features. Retina 28(7):919\u2013930","journal-title":"Retina"},{"issue":"6","key":"1310_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"MJ Elman","year":"2010","unstructured":"Diabetic Retinopathy Clinical Research N, Elman MJ, Aiello LP et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117(6):1064\u20131077 e35","journal-title":"Ophthalmology"},{"issue":"11","key":"1310_CR10","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","volume":"121","author":"JF Korobelnik","year":"2014","unstructured":"Korobelnik JF, Do DV, Schmidt-Erfurth U et al (2014) Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121(11):2247\u20132254","journal-title":"Ophthalmology"},{"issue":"10","key":"1310_CR11","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","volume":"122","author":"DM Brown","year":"2015","unstructured":"Brown DM, Schmidt-Erfurth U, Do DV et al (2015) Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology 122(10):2044\u20132052","journal-title":"Ophthalmology"},{"issue":"4","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","volume":"118","author":"P Mitchell","year":"2011","unstructured":"Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615\u2013625","journal-title":"Ophthalmology"},{"key":"1310_CR13","unstructured":"ClinicalTrials.gov. Treatment for CI-DME in eyes with very good VA study (protocol V). \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01909791\n                    \n                  . Accessed 1 Oct 2018"},{"issue":"1","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/IAE.0000000000002196","volume":"39","author":"M Iglicki","year":"2019","unstructured":"Iglicki M, Busch C, Zur D et al (2019) Dexamethasone implant for diabetic macular edema in naive compared with refractory eyes: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study. Retina 39(1):44\u201351","journal-title":"Retina"},{"key":"1310_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajo.2016.09.002","volume":"172","author":"NV Patrao","year":"2016","unstructured":"Patrao NV, Antao S, Egan C et al (2016) Real-world outcomes of ranibizumab treatment for diabetic macular edema in a united kingdom national health service setting. Am J Ophthalmol 172:51\u201357","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.7150\/ijms.3971","volume":"10","author":"SI Kwon","year":"2013","unstructured":"Kwon SI, Baek SU, Park IW (2013) Comparison of natural course, intravitreal triamcinolone and macular laser photocoagulation for treatment of mild diabetic macular edema. Int J Med Sci 10(3):243\u2013249","journal-title":"Int J Med Sci"},{"issue":"7","key":"1310_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani KG, Nguyen QD (2013) Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond) 27(7):787\u2013794","journal-title":"Eye (Lond)"},{"issue":"5","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamaophthalmol.2015.186","volume":"133","author":"SB Bressler","year":"2015","unstructured":"Bressler SB, Almukhtar T, Bhorade A et al (2015) Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA Ophthalmol 133(5):589\u2013597","journal-title":"JAMA Ophthalmol"},{"key":"1310_CR19","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2147\/OPTH.S114006","volume":"10","author":"S Kiss","year":"2016","unstructured":"Kiss S, Chandwani HS, Cole AL et al (2016) Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema. Clin Ophthalmol 10:2443\u20132453","journal-title":"Clin Ophthalmol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01310-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01310-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01310-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:26:57Z","timestamp":1584750417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01310-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01310-z","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board approval was obtained through the individual IRBs at the participating institutes for a retrospective consecutive chart review. The research adhered to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement or human and animal rights disclosure"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent disclosure"}}]}}